SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-055926
Filing Date
2024-03-01
Accepted
2024-03-01 16:09:30
Documents
5
Effectiveness Date
2024-03-01

Document Format Files

Seq Description Document Type Size
1 S-8 d411386ds8.htm S-8 65981
2 EX-5.1 d411386dex51.htm EX-5.1 12096
3 EX-10.2 d411386dex102.htm EX-10.2 6234
4 EX-23.1 d411386dex231.htm EX-23.1 1578
5 EX-FILING FEES d411386dexfilingfees.htm EX-FILING FEES 16374
  Complete submission text file 0001193125-24-055926.txt   103339
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277587 | Film No.: 24709727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)